Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
34.04%
operating margin TTM
31.84%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | 2.45 |
| peg ratio | 0.02 |
| price to book ratio | 0.45 |
| price to sales ratio | 0.59 |
| enterprise value multiple | 9.67 |
| price fair value | 0.45 |
profitability ratios | |
|---|---|
| gross profit margin | 99.74% |
| operating profit margin | 31.84% |
| pretax profit margin | 34.59% |
| net profit margin | 34.04% |
| return on assets | 14.41% |
| return on equity | 21.31% |
| return on capital employed | 14.84% |
liquidity ratio | |
|---|---|
| current ratio | 8.97 |
| quick ratio | 8.97 |
| cash ratio | 1.60 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 39.93 |
| days of payables outstanding | 5,736.04 |
| cash conversion cycle | -5,696.12 |
| receivables turnover | 9.14 |
| payables turnover | 0.06 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 140.30 |
| cash flow to debt ratio | 113.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.94 |
| cash per share | 6.89 |
| operating cash flow per share | 1.95 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 113.30 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 160.47 |
Frequently Asked Questions
When was the last time Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) reported earnings?
Kiora Pharmaceuticals, Inc. (KPRX) published its most recent earnings results on 08-11-2024.
What is Kiora Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX)'s trailing twelve months ROE is 21.31%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kiora Pharmaceuticals, Inc. (KPRX) currently has a ROA of 14.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KPRX's net profit margin stand at?
KPRX reported a profit margin of 34.04% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KPRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.97 in the most recent quarter. The quick ratio stood at 8.97, with a Debt/Eq ratio of 0.00.